← Eichor
Condition: Choriocarcinoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Choriocarcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Phase 2 · 166 location(s) · Children's Oncology Group · NCT04684368High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors
Phase 2 · 1 location(s) · N.N. Petrov National Medical Research Center of Oncology · NCT06418789Molecular Epidemiology of Pediatric Germ Cell Tumors
Phase N/A · 1 location(s) · Children's Oncology Group · NCT05564026Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ C
Phase 3 · 629 location(s) · Children's Oncology Group · NCT03067181The French National Reference Centre of GTD
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT02892877
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.